Radiological imaging is central to diagnosis, treatment planning, and clinical decision-making. Vision-language foundation models have spurred interest in automated radiology report generation (RRG), but safe deployment requires reliable clinical evaluation of generated reports. Existing metrics often rely on surface-level similarity or behave as black boxes, lacking interpretability. We introduce ICARE (Interpretable and Clinically-grounded Agent-based Report Evaluation), an interpretable evaluation framework leveraging large language model agents and dynamic multiple-choice question answering (MCQA). Two agents, each with either the ground-truth or generated report, generate clinically meaningful questions and quiz each other. Agreement on answers captures preservation and consistency of findings, serving as interpretable proxies for clinical precision and recall. By linking scores to question-answer pairs, ICARE enables transparent, and interpretable assessment. Clinician studies show ICARE aligns significantly more with expert judgment than prior metrics. Perturbation analyses confirm sensitivity to clinical content and reproducibility, while model comparisons reveal interpretable error patterns.
Acquired lymphatic flow disorders include chylothorax, plastic bronchitis, chylous ascites, protein-losing enteropathy, and post-operative lymphocele. These heterogenous clinical entities share common mechanisms and pathophysiology: disruption to normal antegrade flow of lymphatic fluid. Advances in imaging and interventional techniques have improved physicians’ ability to diagnose and treat these diseases. Workup with computed tomography, heavily T2-weighted MRI, and dynamic contrast-enhanced magnetic resonance lymphangiography can elucidate etiologies and provide targets for intervention. Initial management consists of very-low fat diets, medium chain triglyceride supplementation, and pharmacologic therapy with somatostatin analogs. If conservative management fails, interventions like thoracic duct embolization, thoracic duct stent-grafting and decompression, transjugular intrahepatic porto-systemic shunting, and lymphatic channel embolization offer novel, minimally invasive options, with surgery reserved for refractory cases. Future investigations will establish long-term outcomes after thoracic duct embolization, elucidate the relative benefit of thoracic duct embolization versus stent-grafting, and establish standardized treatment algorithms for post-operative lymphocele. In this review, we discuss the etiologies, workup, diagnosis, and management of acquired lymphatic flow disorders.